Prosecution Insights
Last updated: May 29, 2026
Application No. 18/240,939

SYSTEMS AND METHODS FOR DIRECT VISUALIZATION OF A TISSUE LOCATION, SUCH AS AN ENDOCARDIAL LOCATION

Non-Final OA §112
Filed
Aug 31, 2023
Priority
Sep 01, 2022 — provisional 63/403,277
Examiner
JOHNSON, NICOLE F
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Ebr Systems Inc.
OA Round
1 (Non-Final)
87%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allowance Rate
1187 granted / 1358 resolved
+17.4% vs TC avg
Moderate +7% lift
Without
With
+7.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
44 currently pending
Career history
1411
Total Applications
across all art units

Statute-Specific Performance

§101
4.5%
-35.5% vs TC avg
§103
53.2%
+13.2% vs TC avg
§102
33.0%
-7.0% vs TC avg
§112
1.5%
-38.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1358 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 2-5 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected species, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on November 20, 2025. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1, 6-8 & 17-20 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Please see the below reasons: In regards to claim 1, the claim limitation “…in the second configuration, the optical component is positioned at least partially adjacent to the electrical stimulation implant…” is unclear because the claim does not set forth the degree or boundaries of what constitutes “at least partially adjacent.” It is therefore unclear how close the optical component must be to satisfy this limitation. In regards to claim 1, the claim limitation “…capture image data of a region at and/or near the distal opening,” renders the scope of the claim unclear because the spatial extent of “near” is not defined and the use of “and/or” introduces ambiguity as to whether the region must be at the distal opening, near the distal opening or both. In regards to claim 1, the claim limitation “the distal portion of the elongated sheath is configured to expand in cross-sectional dimension when the optical component moves from the first configuration to the second configuration,” is unclear because the claim does not specify the structure or mechanism by which the expansion occurs, nor does it clarify whether the movement of the optical component necessarily causes expansion or merely occurs contemporaneously, i.e. the scope of the limitation is uncertain. In regards to claim 17, the claim limitation “the intermediate member includes at least one finger biased radially inward” is unclear because the claim does not specify the structure or mechanism that provides the recited radial bias. It is therefore unclear how the bias-action is provided and, as a result, the metes and bounds of the claim are uncertain. Allowable Subject Matter The following is a statement of reasons for the indication of allowable subject matter: The closest prior art, as cited above, fails to disclose a method of delivering an electrical stimulation implant comprising positioning an electrical stimulation implant and an optical component positioned proximal to the electrical stimulation implant, and capturing image data of the cardiac tissue proximate to the distal end portion of a sheath with said optical component in a second position, in combination with the other claimed elements. Claims 1, 6-8 & 17-20 are not rejected with prior art rejections. Claims 9-16 are allowed. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICOLE F JOHNSON whose telephone number is (571)270-5040. The examiner can normally be reached Monday-Friday 8:00am-5:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICOLE F JOHNSON/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Aug 31, 2023
Application Filed
Feb 25, 2026
Non-Final Rejection mailed — §112
May 19, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12622668
SYSTEM AND METHOD FOR ASSESSMENT OF CARDIAC STROKE VOLUME AND VOLUME RESPONSIVENESS
3y 5m to grant Granted May 12, 2026
Patent 12622685
LARGE TISSUE DEFECT RECRUITING DEVICE
2y 11m to grant Granted May 12, 2026
Patent 12622747
DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE CLOSURE
2y 5m to grant Granted May 12, 2026
Patent 12616414
SMART CARDIAC ELECTROPHYSIOLOGICAL (EP) MAP
3y 2m to grant Granted May 05, 2026
Patent 12611139
METHODS, SYSTEMS, AND DEVICES FOR DETECTING SLEEP AND APNEA EVENTS
2y 5m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
87%
Grant Probability
95%
With Interview (+7.2%)
2y 8m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1358 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month